ArticleBritish journal of cancer2026

Insights on postneoadjuvant treatment among patients with triple-negative breast cancer and residual disease after neoadjuvant therapy: can expert consensus help to interpret the current evidence?

Antonis Valachis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.